Sculptor Capital LP - CORBUS PHARMACEUTICALS HLDGS ownership

Back to all holdings Add to watchlist

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 84 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2018. The put-call ratio across all filers is 3.04 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Sculptor Capital LP ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q3 2019$1,362,000
-67.3%
279,800
-53.4%
0.01%
+16.7%
Q2 2019$4,160,000
+99.4%
600,000
+100.0%
0.01%0.0%
Q1 2019$2,086,000
-8.4%
300,000
-0.5%
0.01%0.0%
Q3 2018$2,277,000–301,600–0.01%–
 Download
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2018
NameSharesValueWeighting ↓
Ikarian Capital, LLC 397,168$43,8880.01%
CJM Wealth Advisers, Ltd. 30,465$3,3660.00%
Tekla Capital Management LLC 154,310$17,0510.00%
McAdam, LLC 10,006$60.00%
Aries Wealth Management 15,400$1,7020.00%
WELLS FARGO & COMPANY/MN 342,084$37,8000.00%
JPMORGAN CHASE & CO 43,415$50.00%
NORTHERN TRUST CORP 207,329$22,9100.00%
PINNACLE ASSOCIATES LTD 18,580$2,0530.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders